Direct urine sample phenotypic antimicrobial susceptibility testing for identification of effective antimicrobial agents in a single shift.
The blAST assay is not cleared/approved by the U.S. Food and Drug Administration.
For Research Use only. Not for use in Diagnostic Procedures.
CytoSPAR develops transformative technologies for diagnostic and therapeutic products to improve patient lives, lower costs, and simplify healthcare challenges.